FDA
-
-
-
-
-
-
-
Qiagen launches new bloodstream infection panel in Europe
-
-
-
-
-
-
-
QIAGEN delivers solid Q4 2024 growth ahead of outlook
-
-
-
-
-
-
-
QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug
-
-
-
-
-
-
-
QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service
-
-
-
-
-
-
-
QIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2
-
-
-
-
-
-
-
Lab Corp. (LH) Launches Companion Diagnostic for Amgen’s Newly-approved Lung Cancer Therapy
-
-
-
-
-
-
-
Qiagen (QGEN) Receives U.S. FDA Emergency Use Authorization for Fast and Easy-to-Use Digital Test to Detect SARS-CoV-2 Coronavirus Antibodies
-
330,742 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

